Longitudinal validity and reliability of the Myeloma Patient Outcome Scale (MyPOS) was established using traditional, generalizability and Rasch psychometric methods.

scientific article published on 27 July 2017

Longitudinal validity and reliability of the Myeloma Patient Outcome Scale (MyPOS) was established using traditional, generalizability and Rasch psychometric methods. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S11136-017-1660-Z
P932PMC publication ID5655545
P698PubMed publication ID28752440

P50authorIrene HigginsonQ28925108
Richard SiegertQ61796179
P2093author name stringWei Gao
Christina Ramsenthaler
Steve A Schey
Poly M Edmonds
P2860cites workDevelopment and validation of a core outcome measure for palliative care: the palliative care outcome scale. Palliative Care Core Audit Project Advisory GroupQ24654630
The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretationQ24807048
A Systematic Review of the Use of the Palliative Care Outcome Scale and the Support Team Assessment Schedule in Palliative CareQ26786101
The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service researchQ28266484
Validation of the M. D. Anderson Symptom Inventory multiple myeloma moduleQ28703564
Cancer statistics, 2016Q29547383
Improving the assessment of quality of life in the clinical care of myeloma patients: the development and validation of the Myeloma Patient Outcome Scale (MyPOS)Q30641981
The PROMIS Physical Function item bank was calibrated to a standardized metric and shown to improve measurement efficiencyQ33456417
Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infectionQ33650377
Management of gastrointestinal symptoms in advanced cancer patients: the rapid learning cancer clinic model.Q33854239
Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performanceQ70020036
An item analysis which takes individual differences into accountQ72852779
Clinical impact versus factor analysis for quality of life questionnaire constructionQ73271881
Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residualsQ74100209
An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS)Q80245961
Combining distribution- and anchor-based approaches to determine minimally important differences: the FACIT experienceQ81685442
What does the answer mean? A qualitative study of how palliative cancer patients interpret and respond to the Edmonton Symptom Assessment SystemQ83239246
Patient-reported outcomes helped predict survival in multiple myeloma using partial least squares analysis.Q50897397
Assessing the consistency of psychometric properties of the HRQoL scales within the EORTC QLQ-C30 across populations by means of the Mokken Scaling Model.Q51982191
On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation.Q52014630
Comparison of a generic and a disease-specific measure of pain and physical function after knee replacement surgery.Q52017311
Comparative measurement sensitivity of short and longer health status instruments.Q52041377
Three ways to quantify uncertainty in individually applied "minimally important change" values.Q53100692
Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial.Q53403953
Impact of computerized quality of life screening on physician behaviour and patient satisfaction in lung cancer outpatients.Q53518729
Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternativesQ56885135
Quality criteria valuable with slight modificationQ57495613
Reproducibility and responsiveness of evaluative outcome measures. Theoretical considerations illustrated by an empirical exampleQ57830004
Understanding what matters most to people with multiple myeloma: a qualitative study of views on quality of lifeQ34485852
Methods to explain the clinical significance of health status measuresQ34590636
Content development for the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM): use of qualitative and quantitative methods for scale constructionQ36165279
Quality criteria were proposed for measurement properties of health status questionnairesQ36680196
A procedure for evaluating sensitivity to within-person change: can mood measures in diary studies detect change reliably?Q36702014
Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendationsQ37010552
The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper?Q37020343
The prognostic significance of patient-reported outcomes in cancer clinical trialsQ37070024
Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methodsQ37392996
Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendationsQ37532649
Supportive therapies in multiple myelomaQ37624949
The use of two common palliative outcome measures in clinical care and research: a systematic review of POS and STAS.Q37861406
Patient evaluations of hospital care. A review of the literatureQ37965550
What issues matter most to people with multiple myeloma and how well are we measuring them? A systematic review of quality of life tools.Q38044063
Generic and disease-specific measures in assessing health status and quality of lifeQ38606701
European cancer mortality predictions for the year 2016 with focus on leukaemiasQ38915866
Comparative fit indexes in structural modelsQ39513145
Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registryQ39591636
Using the Rasch model in nursing research: an introduction and illustrative exampleQ40021092
An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myelomaQ40202882
Individual-patient monitoring in clinical practice: are available health status surveys adequate?Q40407177
A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK.Q40474917
The use of patient perceptions in the evaluation of health-care delivery systemsQ41641201
Minimally important change determined by a visual method integrating an anchor-based and a distribution-based approach.Q42262425
Measuring quality of life: Using quality of life measures in the clinical settingQ42772293
Effect sizes for interpreting changes in health status.Q43872888
Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapyQ43932593
The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life.Q44193209
Predicting survival in advanced hematologic malignancies: do patient-reported symptoms matter?Q45326786
Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trialQ47203316
Caring for terminal patients in haematology: the urgent need of a new research agendaQ48061874
Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myelomaQ48651395
The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes.Q48661398
A prospective evaluation of patients' health-related quality of life during auto-SCT: a 3-year follow-upQ48743489
What changes in health-related quality of life matter to multiple myeloma patients? A prospective studyQ48919974
Patient online self-reporting of toxicity symptoms during chemotherapyQ48950499
The meaning of patient satisfaction: an explanation of high reported levelsQ50156449
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue11
P304page(s)2931-2947
P577publication date2017-07-27
P1433published inQuality of Life ResearchQ15749950
P1476titleLongitudinal validity and reliability of the Myeloma Patient Outcome Scale (MyPOS) was established using traditional, generalizability and Rasch psychometric methods
P478volume26